307 research outputs found
ACADEMIC SPIN-OFFS FOR THE LOCAL ECONOMY GROWTH
Some research supports the suggestion that start-ups can represent a driver in job creation, economic growth, innovation and competitiveness. In the Entrepreneurship 2020 Action Plan and in the Action Plan on Building a Capital Market Union (2015), one of the main actions is promoting entrepreneurship, to support financing innovation for start-ups, to develop a capital market able to stimulate new business and their growth. Policy makers support start-ups and the university promote its 3rd mission, technology transfer, with a policy of new businesses, with academic spin-offs (ASOs). Academic spin-offs can produce direct and indirect benefits on local economies, but these companies encounter many difficulties to develop. The difficulties of access to finance and lack of managerial skills are the main constraints of growth identified in literature. In the paper, we describe the results of an empirical research on spin–offs of the University of Pisa, with the purpose to capture both the benefits generated in the local area and their contribution to relation capital of the university, but also their difficulties in growth. We found that academic spin-offs have produced important effects on local economies, especially with new jobs, but they reveal some criticisms of financial management behavior, which hampers their development. In the conclusion, we debate about the role of the Capital market Union actions by promoting “financing for innovation” for the growth of academic spin-offs
Recommended from our members
Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment
Chimeric antigen receptor (CAR) T-cell therapy represents a revolutionary treatment for haematological malignancies (i.e. B-ALL). However, the success of this type of treatment has not yet been achieved in solid tumors. One hypothesis is that the immunosuppressive nature of the tumor microenvironment (TME) influences and affects the efficacy of adoptive immunotherapy. Understanding the role of the TME and its interaction with CAR T-cells is crucial to improve the potency of adoptive immunotherapy. In this review, we discuss the strategies and potential combinatorial approaches recently developed in mouse models to enhance the efficacy of CAR T-cells, with particular emphasis on the translational potential of these approaches
Oxidative Stress and Cognitive Decline: The Neuroprotective Role of Natural Antioxidants
Free- radicals (Oxygen and Nitrogen species) are formed in mitochondria during the
oxidative phosphorylation. Their high reactivity, due to not-engaged electrons, leads
to an increase of the oxidative stress. This condition affects above all the brain, that
usually needs a large oxygen amount and in which there is the major possibility to
accumulate “Reacting Species.” Antioxidant molecules are fundamental in limiting freeradical
damage, in particular in the central nervous system: the oxidative stress, in fact,
seems to worsen the course of neurodegenerative diseases. The aim of this review is
to sum up natural antioxidant molecules with the greatest neuroprotective properties
against free radical genesis, understanding their relationship with the Central Nervous
System
FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons
The RNA-binding protein FUS participates in several RNA biosynthetic processes and has
been linked to the pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal
dementia. Here we report that FUS controls back-splicing reactions leading to circular RNA
(circRNA) production. We identified circRNAs expressed in
in vitro
-derived mouse motor
neurons (MNs) and determined that the production of a considerable number of these
circRNAs is regulated by FUS. Using RNAi and overexpression of wild-type and ALS-asso-
ciated FUS mutants, we directly correlate the modulation of circRNA biogenesis with
alteration of FUS nuclear levels and with putative toxic gain of function activities. We also
demonstrate that FUS regulates circRNA biogenesis by binding the introns flanking the
back-splicing junctions and that this control can be reproduced with artificial constructs. Most
circRNAs are conserved in humans and specific ones are deregulated in human-induced
pluripotent stem cell-derived MNs carrying the FUS
P525L
mutation associated with AL
CAR-Based Approaches to Cutaneous T-Cell Lymphoma
Cutaneous T cell lymphomas (CTCL) are a heterogeneous group of malignancies characterized by the expansion of a malignant T cell clone. Chimeric Antigen Receptor (CAR) T cell therapy has shown impressive results for the treatment of B-cell tumors, but several challenges have prevented this approach in the context of T cell lymphoma. These challenges include the possibilities of fratricide due to shared T-cell antigens, T cell immunodeficiency, and CAR transduction of malignant cells if CAR T are manufactured in the autologous setting. In this review, we discuss these and other challenges in detail and summarize the approaches currently in development to overcome these challenges and offer cellular targeting of T cell lymphomas
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
Edad; Terapia anticoagulante; HemorragiaEdat; TerĂ pia anticoagulant; HemorrĂ giaAge; Anticoagulant therapy; HaemorrhageBackground: Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and the disease and treatment-related immune deficiency. The aim of this study was to assess the risk of thrombosis and bleeding in patients with CLL affected by severe COVID-19.
Methods: This is a retrospective multicenter study conducted by ERIC, the European Research Initiative on CLL, including patients from 79 centers across 22 countries. Data collection was conducted between April and May 2021. The COVID-19 diagnosis was confirmed by the real-time polymerase chain reaction (RT-PCR) assay for SARS-CoV-2 on nasal or pharyngeal swabs. Severe cases of COVID-19 were defined by hospitalization and the need of oxygen or admission into ICU. Development and type of thrombotic events, presence and severity of bleeding complications were reported during treatment for COVID-19. Bleeding events were classified using ISTH definition. STROBE recommendations were used in order to enhance reporting.
Results: A total of 793 patients from 79 centers were included in the study with 593 being hospitalized (74.8%). Among these, 511 were defined as having severe COVID: 162 were admitted to the ICU while 349 received oxygen supplementation outside the ICU. Most patients (90.5%) were receiving thromboprophylaxis. During COVID-19 treatment, 11.1% developed a thromboembolic event, while 5.0% experienced bleeding. Thrombosis developed in 21.6% of patients who were not receiving thromboprophylaxis, in contrast to 10.6% of patients who were on thromboprophylaxis. Bleeding episodes were more frequent in patients receiving intermediate/therapeutic versus prophylactic doses of low-molecular-weight heparin (LWMH) (8.1% vs. 3.8%, respectively) and in elderly. In multivariate analysis, peak D-dimer level and C-reactive protein to albumin ratio were poor prognostic factors for thrombosis occurrence (OR = 1.022, 95%CI 1.007‒1.038 and OR = 1.025, 95%CI 1.001‒1.051, respectively), while thromboprophylaxis use was protective (OR = 0.199, 95%CI 0.061‒0.645). Age and LMWH intermediate/therapeutic dose administration were prognostic factors in multivariate model for bleeding (OR = 1.062, 95%CI 1.017-1.109 and OR = 2.438, 95%CI 1.023-5.813, respectively).
Conclusions: Patients with CLL affected by severe COVID-19 are at a high risk of thrombosis if thromboprophylaxis is not used, but also at increased risk of bleeding under the LMWH intermediate/therapeutic dose administration
Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis
Chronic lymphocytic leukemia (CLL) is characterized by the expansion of malignant CD5(+) B lymphocytes in blood, bone marrow and lymphoid organs. CD1d-restricted invariant Natural Killer T (iNKT) cells are innate-like T lymphocytes strongly implicated in tumor surveillance. We investigated the impact of iNKT cells in the natural history of the disease both in EÎĽ;-Tcl1 (Tcl1) CLL mouse model and 68 CLL patients. We found that Tcl1-CLL cells express CD1d and iNKT cells critically delay the disease onset, but become functionally impaired upon disease progression. In patients, disease progression correlates also with high CD1d expression on CLL cells and impaired iNKT cells. Conversely, disease stability correlates with negative/low CD1d expression on CLL cells and normal iNKT cells, suggesting an indirect leukemia control. iNKT cells indeed hinder CLL survival in vitro by restraining CD1d-expressing Nurse Like Cells, a relevant pro-leukemia macrophage population. Finally, multivariate analysis identifies iNKT cell frequency as independent predictor of disease progression. Together, these results support iNKT cell contribution to CLL immune-surveillance and highlight iNKT cell frequency as prognostic marker for disease progression
What Does the Brain Have to Keep Working at Its Best? Resilience Mechanisms Such as Antioxidants and Brain/Cognitive Reserve for Counteracting Alzheimer's Disease Degeneration
here we performed a narrative review highlighting the effect of brain/cognitive reserve and natural/synthetic antioxidants in exerting a neuroprotective effect against cognitive deterioration during physiological and pathological aging. Particularly, we discussed pathogenesis of Alzheimer’s disease, brain and cognitive reserve as means of resilience towards deterioration, and evidence from the literature about antioxidants’ role in sustaining cognitive functioning in the preclinical phase of dementia. During aging, the effects of disease-related brain changes upon cognition are reduced in individuals with higher cognitive reserve, which might lose its potential with emerging cognitive symptoms in the transitional phase over the continuum normal aging-dementia (i.e., Mild Cognitive Impairment). Starting from this assumption, MCI should represent a potential target of intervention in which antioxidants effects may contribute—in part—to counteract a more severe brain deterioration (alongside to cognitive stimulation) causing a rightward shift in the trajectory of cognitive decline, leading patients to cross the threshold for clinical dementia later
- …